In this communication, we reported a series of six patients presented with Guillain-Barré syndrome that associated with COVID-19 infection, which was confirmed with RT-PCR. Here we discuss the laboratory investigation and case management, as well as clinical presentation and outcome of each case. The current report demonstrated the first case series of COVID-19-associated GBS-cases in Sudan.
Keywords: COVID‐19; Guillain‐Barre syndrome; Sudan; ascending paraesthesia; infectious disease; neurological manifestation; neurology.
© 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.